Protagenic Other Operating Expenses vs Interest Expense Analysis

PTIX Stock  USD 0.55  0.08  17.02%   
Protagenic Therapeutics financial indicator trend analysis is much more than just breaking down Protagenic Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Protagenic Therapeutics is a good investment. Please check the relationship between Protagenic Therapeutics Other Operating Expenses and its Interest Expense accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagenic Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Protagenic Stock please use our How to Invest in Protagenic Therapeutics guide.

Other Operating Expenses vs Interest Expense

Other Operating Expenses vs Interest Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Protagenic Therapeutics Other Operating Expenses account and Interest Expense. At this time, the significance of the direction appears to have weak relationship.
The correlation between Protagenic Therapeutics' Other Operating Expenses and Interest Expense is 0.32. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Interest Expense in the same time period over historical financial statements of Protagenic Therapeutics, assuming nothing else is changed. The correlation between historical values of Protagenic Therapeutics' Other Operating Expenses and Interest Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Protagenic Therapeutics are associated (or correlated) with its Interest Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Expense has no effect on the direction of Other Operating Expenses i.e., Protagenic Therapeutics' Other Operating Expenses and Interest Expense go up and down completely randomly.

Correlation Coefficient

0.32
Relationship DirectionPositive 
Relationship StrengthVery Weak

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Protagenic Therapeutics. It is also known as Protagenic Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.
Most indicators from Protagenic Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Protagenic Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagenic Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Protagenic Stock please use our How to Invest in Protagenic Therapeutics guide.Selling General Administrative is likely to drop to about 1.1 M in 2024. Issuance Of Capital Stock is expected to grow at the current pace this year
 2021 2022 2023 2024 (projected)
Reconciled Depreciation37.030.01.6K1.7K
Interest Income33.2K185.8K303.2K318.4K

Protagenic Therapeutics fundamental ratios Correlations

-0.340.1-0.090.65-0.18-0.33-0.030.22-0.19-0.191.0-0.240.58-0.250.68-0.07-0.110.97-0.24-0.24-0.120.93-0.2-0.270.83
-0.34-0.090.54-0.630.360.76-0.48-0.240.370.37-0.310.83-0.260.87-0.230.790.57-0.350.950.830.57-0.220.38-0.28-0.38
0.1-0.09-0.270.260.64-0.210.250.160.640.640.12-0.440.7-0.4-0.04-0.39-0.270.09-0.05-0.44-0.310.230.64-0.440.07
-0.090.54-0.27-0.81-0.10.38-0.980.03-0.1-0.1-0.110.66-0.290.66-0.220.651.0-0.10.560.661.0-0.14-0.09-0.14-0.15
0.65-0.630.26-0.81-0.03-0.520.720.16-0.04-0.040.66-0.640.59-0.650.53-0.53-0.820.67-0.57-0.64-0.820.63-0.05-0.060.65
-0.180.360.64-0.1-0.030.290.13-0.181.01.0-0.15-0.110.35-0.05-0.11-0.14-0.09-0.180.4-0.11-0.080.11.0-0.12-0.13
-0.330.76-0.210.38-0.520.29-0.31-0.790.310.32-0.310.61-0.310.65-0.090.530.42-0.370.710.610.42-0.070.320.03-0.45
-0.03-0.480.25-0.980.720.13-0.31-0.10.130.14-0.01-0.610.15-0.610.16-0.65-0.98-0.04-0.51-0.61-0.970.040.130.2-0.01
0.22-0.240.160.030.16-0.18-0.79-0.1-0.19-0.210.21-0.150.22-0.18-0.05-0.060.010.3-0.22-0.150.0-0.07-0.21-0.280.37
-0.190.370.64-0.1-0.041.00.310.13-0.191.0-0.16-0.10.33-0.04-0.11-0.14-0.09-0.190.4-0.1-0.070.091.0-0.11-0.16
-0.190.370.64-0.1-0.041.00.320.14-0.211.0-0.15-0.10.32-0.04-0.1-0.14-0.09-0.190.4-0.1-0.070.11.0-0.11-0.18
1.0-0.310.12-0.110.66-0.15-0.31-0.010.21-0.16-0.15-0.220.59-0.220.66-0.04-0.130.97-0.2-0.22-0.140.94-0.16-0.30.83
-0.240.83-0.440.66-0.64-0.110.61-0.61-0.15-0.1-0.1-0.22-0.481.0-0.250.970.67-0.250.861.00.68-0.24-0.1-0.16-0.26
0.58-0.260.7-0.290.590.35-0.310.150.220.330.320.59-0.48-0.460.27-0.31-0.30.63-0.2-0.49-0.330.640.31-0.480.7
-0.250.87-0.40.66-0.65-0.050.65-0.61-0.18-0.04-0.04-0.221.0-0.46-0.250.970.67-0.260.891.00.68-0.23-0.03-0.17-0.28
0.68-0.23-0.04-0.220.53-0.11-0.090.16-0.05-0.11-0.10.66-0.250.27-0.25-0.17-0.210.64-0.26-0.25-0.220.67-0.11-0.070.41
-0.070.79-0.390.65-0.53-0.140.53-0.65-0.06-0.14-0.14-0.040.97-0.310.97-0.170.66-0.060.840.970.67-0.09-0.14-0.26-0.06
-0.110.57-0.271.0-0.82-0.090.42-0.980.01-0.09-0.09-0.130.67-0.30.67-0.210.66-0.120.570.670.99-0.15-0.08-0.15-0.18
0.97-0.350.09-0.10.67-0.18-0.37-0.040.3-0.19-0.190.97-0.250.63-0.260.64-0.06-0.12-0.25-0.25-0.130.89-0.2-0.280.89
-0.240.95-0.050.56-0.570.40.71-0.51-0.220.40.4-0.20.86-0.20.89-0.260.840.57-0.250.860.59-0.10.41-0.25-0.24
-0.240.83-0.440.66-0.64-0.110.61-0.61-0.15-0.1-0.1-0.221.0-0.491.0-0.250.970.67-0.250.860.68-0.24-0.1-0.16-0.27
-0.120.57-0.311.0-0.82-0.080.42-0.970.0-0.07-0.07-0.140.68-0.330.68-0.220.670.99-0.130.590.68-0.16-0.07-0.1-0.18
0.93-0.220.23-0.140.630.1-0.070.04-0.070.090.10.94-0.240.64-0.230.67-0.09-0.150.89-0.1-0.24-0.160.09-0.240.74
-0.20.380.64-0.09-0.051.00.320.13-0.211.01.0-0.16-0.10.31-0.03-0.11-0.14-0.08-0.20.41-0.1-0.070.09-0.11-0.18
-0.27-0.28-0.44-0.14-0.06-0.120.030.2-0.28-0.11-0.11-0.3-0.16-0.48-0.17-0.07-0.26-0.15-0.28-0.25-0.16-0.1-0.24-0.11-0.25
0.83-0.380.07-0.150.65-0.13-0.45-0.010.37-0.16-0.180.83-0.260.7-0.280.41-0.06-0.180.89-0.24-0.27-0.180.74-0.18-0.25
Click cells to compare fundamentals

Protagenic Therapeutics Account Relationship Matchups

Protagenic Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets842.3K879.2K11.1M8.0M4.3M4.1M
Other Current Liab1.2M513.3K520.6K620.1K541.5K514.4K
Total Current Liabilities1.2M655.2K799.5K1.1M655.3K622.5K
Total Stockholder Equity(634.4K)(1.1M)9.9M6.9M3.7M6.1M
Property Plant And Equipment Net611.0296.00.01.8K123.3K117.2K
Net Debt(519.3K)702.7K(222.7K)129.0K(1.3M)(1.4M)
Retained Earnings(15.2M)(17.7M)(22.2M)(25.8M)(30.8M)(32.3M)
Cash798.6K671.1K541.2K215.2K1.3M2.0M
Non Current Assets Total611.0296.00.01.8K123.3K117.2K
Non Currrent Assets Other1.0K611.0296.01.8K(1.0)(0.95)
Cash And Short Term Investments798.6K671.1K10.4M8.0M4.1M4.0M
Liabilities And Stockholders Equity842.3K879.2K11.1M8.0M4.3M4.1M
Non Current Liabilities Total161.052.4K279.4K1.4M318.4K1.0M
Other Current Assets43.4K208.2K688.7K56.9K144.0K136.8K
Other Stockholder Equity14.7M16.7M32.4M33.4M34.6M42.6M
Total Liab1.5M2.0M1.1M1.1M655.3K622.5K
Total Current Assets842.0K879.2K11.1M8.0M4.2M7.2M
Accumulated Other Comprehensive Income(172.4K)(171.6K)(248.3K)(676.9K)(113.5K)(119.2K)
Accounts Payable36.2K141.9K279.0K155.5K113.8K108.1K
Net Tangible Assets(210.9K)(634.4K)(1.1M)9.9M11.4M12.0M
Net Invested Capital(355.0K)224.1K10.3M7.3M3.7M3.5M
Net Working Capital(355.3K)224.1K10.3M6.9M3.5M3.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Protagenic Stock Analysis

When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.